Nicotine Lozenge
Product Images NDC 63548-0262

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 63548-0262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pld Acquisitions Llc Dba Av�ma Pharma Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine Polacrilex 4 mg (Nicotine Polacrilex Lozenge Mini 4mg 2mg 1)

Nicotine Mini Nicotine Polacrilex Lozenge 4 mg Mint Flavor packaging label. The front displays the product name with strength, mint flavor, and quantity of 108 lozenges (4 vials of 27). Labeler Avema Pharma Solutions is noted. Additional panels include Drug Facts with active ingredient nicotine polacrilex 4 mg, usage, warnings, directions, and contact information for quitting support.*

FDA Label Image

Nicotine Polacrilex 2 mg (Nicotine Polacrilex Lozenge Mini 4mg 2mg 2)

Nicotine Mini 2 mg Mint Flavor lozenge packaging label, containing 108 lozenges (4 vials of 27). The label highlights nicotine polacrilex as the active ingredient and states its purpose as a stop smoking aid. The label includes usage instructions, warnings, and directions for use. Manufactured by Avéma Pharma Solutions, Miami, FL, the label also features a quit smoking hotline number and tamper-evident warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.